Fitness enthusiasts cutting or maintaining lean muscle
Why Cedar City City Chooses Potere Health MD Potere Health MD offers physician-led tirzepatide and semaglutide care (GLP-1) in Cedar City for patients who want the trust, accountability, and personal attention of a local doctor with the convenience of in-person or fully online care

Absolute Contraindications BPC-157 is not recommended for patients with: Active cancer (any type) theoretical concern regarding angiogenesis promotion Pregnancy or breastfeeding insufficient safety data Known hypersensitivity to any component of the formulation Relative Contraindications (Require Individualized Assessment) History of cancer after completion of treatment, a waiting period and oncology clearance may be appropriate Autoimmune disease especially if active or requiring immunosuppressive therapy Anticoagulant use injection site bleeding risk, though minimal with proper technique Severe renal or hepatic impairment dosing adjustments may be needed Monitoring and Follow-Up Patients on BPC-157 protocols are monitored through: Baseline and follow-up labs including inflammatory markers (CRP, ESR), complete blood count, and metabolic panel Clinical assessments pain scores, range of motion, functional outcomes at 2-week, 4-week, and 8-week intervals Imaging when indicated repeat ultrasound or MRI for musculoskeletal conditions to document structural healing The Patient Journey: What to Expect For patients considering peptide therapy, understanding the timeline of response helps set realistic expectations

Reply My Dr wrote an RX for Wegovy injection
Approved in December 2025, it provides the same effective GLP-1 performance
Can delayed gastric emptying cause constipation or digestive discomfort